- Ligand Pharmaceuticals (NASDAQ:LGND): Q1 EPS of $0.33 beats by $0.06.
- Revenue of $14.60M (-8.5% Y/Y) beats by $1.07M.
- Press Release
Ligand Pharmaceuticals beats by $0.06, beats on revenue
Recommended For You
More Trending News
About LGND Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LGND | - | - |
| Ligand Pharmaceuticals Incorporated | ||